#icans search results
Real-world data showed that #CRS occurred in 95% (n = 42) of patients with B-cell malignancies, all of which were characterized as grade 1 or 2 events, and #ICANS occurred in 9% (n = 4) of patients and was grade 1/2 in 1% of cases and grade 3/4 in 3%. hubs.li/Q03j_h4_0
In this episode of the Neurology Podcast, Dr. Derek Stitt @brainsnthingz talks with Dr. Rachna Malani about the potential neurotoxicity associated with CAR-T therapy. Listen now: bit.ly/3Xo5VQG #NeuroTwitter #Neurology #ICANS
Neurology Podcast: Dr. Alison Christy and Dr. Jennifer McGuire discuss neuroimaging findings linked to #ICANS, exploring whether specific imaging patterns correlate with distinct neurologic symptoms. Listen now: hubs.la/Q03RJ3SY0 #NeuroTwitter #NeuroX
Siltuximab May Be Effective Treatment for CRS/ICANS Following CAR T-Cell Therapy #CARTcelltherapy #CRS #ICANS #Oncology #Nursing #Tandem23 @ASTCT ow.ly/10lm50Nlwgv
🆕️Consensus recommendations on the management of toxicity with CD3×CD20 bispecific antibody therapy🏅 by Crombie ➡️Comparison between CD3×CD20 BsAbs in NHL ➡️CRS management ➡️Neurotoxicity management 🌍Blood 18 APRIL 2024 | VOLUME 143, NUMBER 16 #lymphoma #BiTE #ICANS #CRS #Hem
Ha sido un honor haber participado en el VI Symposium del @Grupo_GELL para hablar sobre el mecanismo de acción de los anticuerpos biespecíficos en #linfoma, sus consecuencias inmunológicas con #CRS y #ICANS, cómo prevenirlos, cómo identificarlos y cómo tratarlos #lymsm
Very interesting talk by Bianca Santommasso, MSKCC about ICANS management in the 6th European CAR-T meeting in Valencia. #cart #icans #neurology
Our very own @hopkinskimmel Dr @TaniaJain11 talking to a packed room (with standing audience as well as people seating on the floor) about #ICANS #TANDEM23 @ASTCT #TaniaJain #IwasthereDrJain #DatingApp?🤯
Excellent and timely “How I treat” review on refractory #CRS and #ICANS in #CARTcell therapy for #lymsm by @MichaelDJain eT al ashpublications.org/blood/article/…
Nerve damage-tracking pen from @Manusneuro to be used in @JNJnews CAR-T #celltherapy study for early detection of #ICANS pharmaphorum.com/news/nerve-dam…
Small, simple habits — like a 30-minute weekly walk — can transform your relationship with your kids. Read more for practical goals you can start today! 👇 #DadLife #FamilyBonds #ICANS #FatherhoodSuccess buff.ly/lfo9Tdn
Allison Tanner, PA-C, reviewed the recognition and management of #CRS, #ICANS, and other evolving toxicities associated with #CAR-T therapy and bispecific antibodies, emphasizing the need for clinician readiness as cellular therapies expand. Learn more: hubs.ly/Q041C_Ht0
🧠 Neurotoxicity, cardiotoxicity, cytopenias... All can follow CAR T-cell therapy. Learn to identify & act—fast. 🎥 Free CME webcast: ce.ceconcepts.com/WCV-095 #OncologyED #TcellTherapies #ICANS #CAR-T
Recently published: Hypophosphatemia correction reduces #ICANS incidence and duration in CAR T-cell therapy: a pooled clinical trial analysis, by Jack Pengfei Tang et al. bit.ly/3zgwEbv @SheilaSDiamond @dgsomucla @UCLAstemcell @Medidata @Stanford_Neuro #openaccess
What a month of December 2023. This time big congratulations to Manon who won the best presentation award from the Chemistry doctoral school ED222 @unistra ! 👏👏👏 @CNRS_Alsace @ERC_Research @IMStrasbourg #ICANS @SynpaTeam @IPHC_Strasbourg
Retrouvez nous à l'Institut de cancérologie de #Strasbourg #ICANS mardi 16 avril 9h30-17h pour discuter 🗣️☕️ et vous présenter l'association ELLyE. Venez nombreux ! #GrandEst @ars_grand_est #lymphomes #leucémiechroniquelymphoïde #maladiedeWaldenström
Could #ICANS after antiCD19 CAR-T be less “benign” than we thought? In a case-control study from the @VHIO CAR-T cohort, patients with more severe ICANS (≥grade2) showed signs of neuroaxonal damage during the episode! 💡Could prevention or earlier treatment change the story?
No link between baselines congnitive performance and #ICANS onset; NfL levels independendly associated with #ICANS #carTcells #lymphoma @HopSaintLouis #PreceptorshipLymphomas
Don’t miss the education session in BMT and CAR T management #Tandem23 management pearls for #CRS #ICANS #cytopenias #GVHD #CART #BMTsm by Drs. @ReshmaRamlal2 @NiraliShahMD Cathy Lee Annie Im at noon - reminder for @GvHD_Meade @hopkinskimmel @UKMarkey @UofUHealth @UPMCHillmanCC
J’entends ici et là que des médecins seraient empêchés de travailler ou que des patients verraient leur prise en charge dégradée … #icans #lespatientsdabord #bienetreautravail @AF_Pons
Attention aux patients ! Ils ne doivent pas faire les frais de ça ⤵️⤵️⤵️ rue89strasbourg.com/scandale-polit…
ESS Bilbao #Target division has been participated in the #ICANS conference, where they are sharing with the scientific community the developments carried out within the Dump‑IT, Vessel Design for a Spectrometer at TS2‑SNS, and #Argitu projects.
@BilbaoEss Antoni Simelio, Instrument division, during the poster session at #ICANS congress highlighting the latest advances in the experimental station of the #MIRACLES spectrometer at @essneutron
#trendings 1. A “simple” tremor wasn’t simple. G3 ICANS with seizure in R/R DLBCL. Stay alert. #CARTcell #ICANS 2. Tremor → dysgraphia → G3 ICANS. CAR T therapy needs sharp monitoring. 3. Not just a tremor. G3 ICANS with electrographic seizures
Prof. Dok Hyun Yoon discusses a patient with R/R DLBCL whose hand tremor with dysgraphia turned out to be G3 ICANS with electrographic seizure, in this on-demand Masterclass. Hear more from our panel of experts on their experiences in CAR T-cell therapy for R/R DLBCL or R/R FL.
🩸Facts about Multiple Myeloma: Adverse Events and Management #CRS #ICANS #Neurotoxicity #Neutropenia #Teclistamab #MajesTEC3 #Immunotherapy #Tocilizumab #Hematology #RareDiseases #BloodDisorders #ClinicalInsights #MedEd #HEMEHUB
Allison Tanner, PA-C, reviewed the recognition and management of #CRS, #ICANS, and other evolving toxicities associated with #CAR-T therapy and bispecific antibodies, emphasizing the need for clinician readiness as cellular therapies expand. Learn more: hubs.ly/Q041C_Ht0
📄 New paper out! Our study shows that MRI white matter microstructural damage may predict ICANS risk in CAR-T patients. Proud of this collaborative work! #CAR-T #ICANS #Neuroimaging #MRI #Research doi.org/10.1111/jon.70…
Small, simple habits — like a 30-minute weekly walk — can transform your relationship with your kids. Read more for practical goals you can start today! 👇 #DadLife #FamilyBonds #ICANS #FatherhoodSuccess buff.ly/lfo9Tdn
🧠 Neurotoxicity, cardiotoxicity, cytopenias... All can follow CAR T-cell therapy. Learn to identify & act—fast. 🎥 Free CME webcast: ce.ceconcepts.com/WCV-095 #OncologyED #TcellTherapies #ICANS #CAR-T
🧠 Neurotoxicity, cardiotoxicity, cytopenias... All can follow CAR T-cell therapy. Learn to identify & act—fast. 🎥 Free CME webcast: ce.ceconcepts.com/WCV-095 #OncologyED #TcellTherapies #ICANS #CAR-T
Links to sessions and abstract pdfs below. ABSTRACT ID abs25-1652 ABSTRACT ID 928 High-dose anakinra to treat refractory immune effector cell-associated neurotoxicity syndrome in CAR T-cell therapy recipient. Pdf: meetings-api.hematology.org/api/abstract/v… Session: submit.hematology.org/program/presen… #ICANS
🚑 Patient on CAR T presents with altered mental status... What’s your next move? 🎓 This CME equips you to manage neurotoxicity, CRS & more. 📲 ce.ceconcepts.com/WCV-095 #ICANS #CRS #CancerImmunotherapy #EMCare
🚑 Patient on CAR T presents with altered mental status... What’s your next move? 🎓 This CME equips you to manage neurotoxicity, CRS & more. 📲 ce.ceconcepts.com/WCV-095 #ICANS #CRS #CancerImmunotherapy #EMCare
My review on CAR-T and CAR-T cell therapy-associated neurotoxicity in pre-print yesterday #CART #ICANS jni-journal.com/callback?red_u…
Hot off the press today, check out our super talented PhD student, Christina Kazzi's paper: How a simple clock drawing test can complement current #ICANS assessment in #CART patients. Well done Christina! 👏 @MonashSTM @AlfredHealth CART program. onlinelibrary.wiley.com/doi/10.1111/bj…
Great news! Our collaborative work led by Marina Gomez-Gobell is out — exploring serum and CSF cytokine profiling in CAR-T–related neurotoxicity. Now published in Bone Marrow Transplantation. #CART #Neurotoxicity #ICANS 🔗 rdcu.be/exG18
New in @BMTjournal ICANS risk models after CD19 #CARTcell therapy using cytokines (IL-6, IL-15, GM-CSF) + CSF 🧠🧪 Grateful to my mentors at @HematoHGUGM and our amazing team 🧠💊 and collaborators 🔗 rdcu.be/exIka #ICANS #Neurotoxicity #Immunotherapy
ベースラインの認知機能および神経学的状態は、侵襲性B細胞リンパ腫に対するCAR-T細胞療法におけるICANSの発現に影響を与えない onlinelibrary.wiley.com/doi/10.1111/en… 免疫エフェクター細胞関連 神経毒性症候群（#ICANS）: 血液がんに対する #CAR_T 細胞療法でよくみられる重篤な合併症 血清中 #NFL を
Fino al 50% dei pazienti CAR-T sviluppa ICANS, grave neurotossicità. Afasia, convulsioni, encefalopatia: l’infermiere ematologico è cruciale per cogliere i primi segnali. Biomarcatori come ferritina e NfL aprono a nuovi modelli predittivi. #CAR_T #ICANS
Huge thanks to our funding agencies - #SNSF, @ERC_Research @Liguecancer67, #IMSstrasbourg, and generous donors to #ICANS. Special thanks to all collaborators from @unistra, @Inserm @GoetzJacky Céline Mirjolet and team members
16/🔑Adverse events w/ idecabtagene vicleucel & ciltacabtagene autoleucel appear similar to each other 🔑 Frequency & severity of myelosuppression, #infection, CRS & #ICANS are ⬆️w/ BCMA-directed #CART therapies compared to BCMA-directed bispecific antibodies
Immune Effector Cell Associated Neurotoxicity Syndrome (#ICANS) remains a key challenge for safe use in #CARTcellTherapy. My @Medidata colleagues co-authored a poster with @EHA_Hematology exploring the best approaches to treatment. Read more: mdso.io/7rj
Can We Prevent CAR T-Associated Neurotoxicity Without Compromising Efficacy? mediamedic.co/can-we-prevent… linkedin.com/feed/update/ur… #EBMT25 #ICANS #Neurotoxicity #CART #OncologyResearch #Immunotherapy #Microglia #CellTherapy
Interested in #CARTcells? Read the review on "Novel pathophysiological insights into CAR-T cell associated #neurotoxicity", in @FrontNeurol by @GCIR_Unige member Prof. @MiglioriniDenis! 👉bit.ly/3m4tpNs #ICANS #glioma #immunotherapy @Hopitaux_unige @DOncologie @unige_en
Allison Tanner, PA-C, reviewed the recognition and management of #CRS, #ICANS, and other evolving toxicities associated with #CAR-T therapy and bispecific antibodies, emphasizing the need for clinician readiness as cellular therapies expand. Learn more: hubs.ly/Q041C_Ht0
Neurotoxicity associated with #CARTcell therapy has distinct common features which are incorporated into the consensus grading system. Assessment and determination of the #ICE score is necessary for grading #ICANS. Source: bit.ly/3NahitF
Immune Effector Cell Associated Neurotoxicity Syndrome (#ICANS) remains a key challenge for safe use in #CARTcellTherapy. My @Medidata colleagues co-authored a poster with @EHA_Hematology exploring the best approaches to treatment. Read more: mdso.io/7rj
#ICANS grading is the #ICE score combined with other neurologic domains including level of consciousness, motor symptoms, seizures, and signs of elevated intracranial pressure/cerebral edema, which may occur with or without encephalopathy. Source: bit.ly/3NahitF
Fino al 50% dei pazienti CAR-T sviluppa ICANS, grave neurotossicità. Afasia, convulsioni, encefalopatia: l’infermiere ematologico è cruciale per cogliere i primi segnali. Biomarcatori come ferritina e NfL aprono a nuovi modelli predittivi. #CAR_T #ICANS
Real-world data showed that #CRS occurred in 95% (n = 42) of patients with B-cell malignancies, all of which were characterized as grade 1 or 2 events, and #ICANS occurred in 9% (n = 4) of patients and was grade 1/2 in 1% of cases and grade 3/4 in 3%. hubs.li/Q03j_h4_0
Ha sido un honor haber participado en el VI Symposium del @Grupo_GELL para hablar sobre el mecanismo de acción de los anticuerpos biespecíficos en #linfoma, sus consecuencias inmunológicas con #CRS y #ICANS, cómo prevenirlos, cómo identificarlos y cómo tratarlos #lymsm
Recently published: Hypophosphatemia correction reduces #ICANS incidence and duration in CAR T-cell therapy: a pooled clinical trial analysis, by Jack Pengfei Tang et al. bit.ly/3zgwEbv @SheilaSDiamond @dgsomucla @UCLAstemcell @Medidata @Stanford_Neuro #openaccess
En RCP avec les collègues du Hanoï Oncology Hospital. Toujours un plaisir d'échanger avec nos amis du #Vietnam ! #ICANS
🆕️Consensus recommendations on the management of toxicity with CD3×CD20 bispecific antibody therapy🏅 by Crombie ➡️Comparison between CD3×CD20 BsAbs in NHL ➡️CRS management ➡️Neurotoxicity management 🌍Blood 18 APRIL 2024 | VOLUME 143, NUMBER 16 #lymphoma #BiTE #ICANS #CRS #Hem
Retrouvez nous à l'Institut de cancérologie de #Strasbourg #ICANS mardi 16 avril 9h30-17h pour discuter 🗣️☕️ et vous présenter l'association ELLyE. Venez nombreux ! #GrandEst @ars_grand_est #lymphomes #leucémiechroniquelymphoïde #maladiedeWaldenström
Don’t sleep on the saga and all the awesome #giveaways by @Skullbombsnft $PEPE #iCans #skullbombs IRL 3D, and real $ETH Join the community now @ozcartech @JaiLovesCrypto @silvertre21 and we will welcome you with #SkullLove
📅 Jusqu'au 6 sept, venez à l'Institut de cancérologie de #ICANS nous rencontrer & laissez un message de soutien dans le studio mobile du podcast 🎤 "Cancers du Sang, Nos Vies" ! 🚐 #Strasbourg est le 1er arrêt de ce projet itinérant (du 4 au 6 sept). #MoisDesCancersDuSang
Immune Effector Cell Associated Neurotoxicity Syndrome (#ICANS) remains a key challenge for safe use in #CARTcellTherapy. My @Medidata colleagues co-authored a poster with @EHA_Hematology exploring the best approaches to treatment. Read more: mdso.io/7rj
Immune Effector Cell Associated Neurotoxicity Syndrome (#ICANS) remains a key challenge for safe use in #CARTcellTherapy. My @Medidata colleagues co-authored a poster with @EHA_Hematology exploring the best approaches to treatment. Read more: mdso.io/7rj
No link between baselines congnitive performance and #ICANS onset; NfL levels independendly associated with #ICANS #carTcells #lymphoma @HopSaintLouis #PreceptorshipLymphomas
Something went wrong.
Something went wrong.
United States Trends
- 1. Spirit N/A
- 2. New Day N/A
- 3. Kentucky Derby N/A
- 4. Ian Happ N/A
- 5. T O Elvis N/A
- 6. Kofi N/A
- 7. Ben Brown N/A
- 8. Jeeves N/A
- 9. Cody Bellinger N/A
- 10. Rhett Lowder N/A
- 11. Crude Velocity N/A
- 12. Pocahontas N/A
- 13. Elizabeth Warren N/A
- 14. Dagen N/A
- 15. Andrew Painter N/A
- 16. Crypto Pump News N/A
- 17. Hardball N/A
- 18. Jake Bird N/A
- 19. #Its_SevEN_In_This_World N/A
- 20. Big E N/A